Kevin Ryan, one of New York’s most influential technology entrepreneurs and investors, believes the biggest opportunities often appear before the rest of the market recognizes their potential.
From psychedelics to artificial intelligence, Ryan has built a reputation for backing emerging industries before they become mainstream.
Now, as venture capital enters a new era shaped by AI and mega-investments, his firm AlleyCorp is preparing to place another major bet on the next generation of startups.
From Psychedelic Skeptic to Billion-Dollar Investor
Ryan was not always convinced that psychedelic drugs could become legitimate medical treatments.
The entrepreneur, often described as the “Godfather of NYC Tech,” initially questioned whether psychedelics could play a meaningful role in treating conditions such as depression and PTSD.
That changed in 2018 after reading Michael Pollan’s book How to Change Your Mind, which introduced him to a growing body of scientific research surrounding psychedelic medicine.
The shift in perspective led Ryan to become a supporter of the Yale Center for Psychedelic Research and later cofound Transcend Therapeutics, a company focused on psychoactive drug development.
The business was eventually acquired in June for $1.2 billion.
Ryan said his investment philosophy is built around identifying trends before they become obvious to the wider market.
“If something is obvious, it is already worth billions and it is too late,” he explained, arguing that early conviction is where the biggest opportunities exist.
AlleyCorp Returns With Bigger Venture Fund
Ryan’s investment firm AlleyCorp is continuing its expansion with the launch of a new $335 million fund.
The move follows the firm’s first outside fundraising effort in 2024, when it secured a $250 million fund after previously operating mainly as a family office.
Over the years, AlleyCorp has helped create and invest in dozens of companies, including major technology names such as MongoDB, Business Insider, Gilt Groupe and Zola.
The firm has also built a strong track record, with one source familiar with its financial performance saying previous investments have produced an estimated 60% internal rate of return.
Staying Focused on Early-Stage Companies
Despite changes across the venture capital industry, Ryan said AlleyCorp’s approach remains largely unchanged.
The firm continues to focus on making early investments in companies that are still developing their products, customers and business models.
Ryan said AlleyCorp recently invested in a company valued at $25 million that had generated only $500,000 in revenue, emphasizing that helping founders build businesses remains central to the firm’s strategy.
The firm currently invests across healthcare, deep technology and general technology sectors and has eight unicorn companies in its portfolio, including Rogo, ShopMy, Valar Atomics and Thyme Care.
Ryan Questions the Future of Traditional Venture Capital
The rapid rise of artificial intelligence has transformed the venture capital landscape, with enormous amounts of money flowing into a small number of AI companies.
Ryan believes some of these massive investments should not be considered traditional venture capital because they involve companies already operating at a scale comparable to public corporations.
He pointed to companies such as Anthropic and OpenAI, arguing that billion-dollar investments into firms valued at hundreds of billions represent a different category of financing.
According to Ryan, the flood of capital into AI giants may make overall venture investment numbers appear misleading, as removing those companies from the equation would create a very different picture.
Bigger Funds Could Come Without Changing Strategy
Although AlleyCorp currently focuses on smaller early-stage investments, Ryan said he is open to raising larger funds in the future.
He explained that venture investing should be defined by investment stage and check size rather than the total size of a fund.
A future AlleyCorp fund could potentially reach $500 million or $600 million, but Ryan said expansion would likely come through adding new areas of expertise or expanding geographically rather than abandoning the firm’s original approach.
For example, a larger fund could allow the company to build specialized teams in areas such as biotechnology while continuing to invest in young companies.
AI Has Changed the Speed of Innovation
Ryan believes the pace of technological change has become difficult to predict.
He recalled that years ago many experts expected autonomous vehicles to become widespread by 2026, yet fully driverless transportation remains far from reality.
At the same time, he said the speed of AI development has exceeded expectations, creating an environment where yesterday’s technology breakthroughs can quickly become outdated.
Ryan pointed to recent developments in artificial intelligence as evidence of how quickly the industry can shift, noting that major AI companies discussed today were barely part of conversations just over a year ago.
Adapting Is the Key Skill in a Fast-Moving World
As technology continues to evolve rapidly, Ryan believes the ability to adjust perspectives may be one of the most valuable skills for investors and entrepreneurs.
His own journey—from skepticism about psychedelics to backing a billion-dollar company, and from early internet investments to navigating the AI boom—reflects the importance of changing opinions when new information emerges.
For Ryan and AlleyCorp, the strategy remains simple: identify promising ideas early, support ambitious founders and invest before the rest of the market catches up.
